Device Firms Will Collaborate With Pharma, Rather Than Merge – Hawkins
This article was originally published in The Gray Sheet
Executive Summary
Mergers of drug discovery companies with device developers will remain rare, even as collaborations across the drug, device and biologics industries become more common, Medtronic COO Bill Hawkins maintains